Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +48.81%
#3 Black Phoenix Black Phoenix +34.78%
#4 Velvet Velvet +31.18%
#5 Cross Cross +22.45%
#6 Akedo Akedo +17.41%
#7 DoubleZero DoubleZero +14.34%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.22%
#9 Cap Cap +10.26%
#10 Fake World Assets Fake World Assets +10.23%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Epitomee Medical Ltd Epitomee Medical Ltd

Epitomee Medical Ltd

EPIT
Rangering i aksjer #39745
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices... Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Aksjekurs
$1.20
Markedsverdi
$361.35K
Endring (1 dag)
-3.52%
Endring (1 år)
-52.92%
Land
IL
Handel Epitomee Medical Ltd (EPIT)

Kategori

Healthcare
Inntekter for Epitomee Medical Ltd (EPIT)
Inntekter i 2026 TTM: 0
Ifølge Epitomee Medical Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Epitomee Medical Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US